Showing results (1571-1580 of 1,605) with videos related to

Sort By:
Pageof 161
JCI Insight|October 10, 2022
Vaccine breakthrough infection leads to distinct profiles of neutralizing antibody responses by SARS-CoV-2 variantMichael S Seaman, Mark J Siedner, Julie Boucau, et al.
Lung Cancer (Amsterdam, Netherlands)|November 23, 2023
Disparities in outcomes between Black and White patients in North America with thoracic malignancies and COVID-19 infection (TERAVOLT)Laura Burns, Chih-Yuan Hsu, Jennifer G Whisenant, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 3, 2016
The BATTLE-2 Study: A Biomarker-Integrated Targeted Therapy Study in Previously Treated Patients With Advanced Non-Small-Cell Lung CancerVassiliki Papadimitrakopoulou, J Jack Lee, Ignacio I Wistuba, et al.
Nature|April 6, 2022
FcγR-mediated SARS-CoV-2 infection of monocytes activates inflammationCaroline Junqueira, Ângela Crespo, Shahin Ranjbar, et al.
Pigment Cell & Melanoma Research|August 1, 2022
Melanoma central nervous system metastases: An update to approaches, challenges, and opportunitiesAlcida Karz, Maya Dimitrova, Kevin Kleffman, et al.
JAMA Oncology|April 10, 2020
Durvalumab With or Without Tremelimumab vs Standard Chemotherapy in First-line Treatment of Metastatic Non-Small Cell Lung Cancer: The MYSTIC Phase 3 Randomized Clinical TrialNaiyer A Rizvi, Byoung Chul Cho, Niels Reinmuth, et al.
European Heart Journal|May 31, 2024
Transcatheter heart valve explant with infective endocarditis-associated prosthesis failure and outcomes: the EXPLANT-TAVR international registryMateo Marin-Cuartas, Gilbert H L Tang, Philipp Kiefer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2018
FDA Approval Summary: Niraparib for the Maintenance Treatment of Patients with Recurrent Ovarian Cancer in Response to Platinum-Based ChemotherapyGwynn Ison, Lynn J Howie, Laleh Amiri-Kordestani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 16, 2019
EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancerK Hastings, H A Yu, W Wei, et al.
The Journal of Clinical Investigation|July 1, 2021
SARS-CoV-2 viremia is associated with distinct proteomic pathways and predicts COVID-19 outcomesYijia Li, Alexis M Schneider, Arnav Mehta, et al.
Pageof 161